97 related articles for article (PubMed ID: 18459585)
21. A grading study of gliomas using computer aided malignancy classification and histologic morphometry.
Sharma S; Karak AK; Sarkar C; Gomathy G; Banerji AK; Schmitt HP
J Neurooncol; 1996 Jan; 27(1):75-85. PubMed ID: 8699229
[TBL] [Abstract][Full Text] [Related]
22. Automated grading of astrocytomas based on histomorphometric analysis of Ki-67 and Feulgen stained paraffin sections. Classification results of neuronal networks and discriminant analysis.
Kolles H; von Wangenheim A; Vince GH; Niedermayer I; Feiden W
Anal Cell Pathol; 1995 Mar; 8(2):101-16. PubMed ID: 7786811
[TBL] [Abstract][Full Text] [Related]
23. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
24. Automated diagnosis of brain tumours astrocytomas using probabilistic neural network clustering and support vector machines.
Glotsos D; Tohka J; Ravazoula P; Cavouras D; Nikiforidis G
Int J Neural Syst; 2005; 15(1-2):1-11. PubMed ID: 15912578
[TBL] [Abstract][Full Text] [Related]
25. Numerical grading of astrocytomas.
Schad LR; Schmitt HP; Oberwittler C; Lorenz WJ
Med Inform (Lond); 1987; 12(1):11-22. PubMed ID: 3035294
[TBL] [Abstract][Full Text] [Related]
26. [Classification of the astrocytic gliomas. Brief comments].
Pérez-Ortiz L; Galarraga J; Gómez-Suárez H; Tamayo-Suárez JD
Rev Neurol; 2000 Dec 16-31; 31(12):1180-3. PubMed ID: 11205555
[TBL] [Abstract][Full Text] [Related]
27. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
[TBL] [Abstract][Full Text] [Related]
28. Grading astrocytomas.
Adelman LS
Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
[TBL] [Abstract][Full Text] [Related]
29. Morphometrically assisted grading of astrocytomas.
Scarpelli M; Bartels PH; Montironi R; Galluzzi CM; Thompson D
Anal Quant Cytol Histol; 1994 Oct; 16(5):351-6. PubMed ID: 7840841
[TBL] [Abstract][Full Text] [Related]
30. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
31. Revisiting anaplastic astrocytomas II: further characterization of an expansive growth pattern with visually enhanced diffusion tensor imaging.
Guan X; Lai S; Lackey J; Shi J; Techavipoo U; Moulding HD; Flanders AE; Andrews DW
J Magn Reson Imaging; 2008 Dec; 28(6):1322-36. PubMed ID: 19025901
[TBL] [Abstract][Full Text] [Related]
32. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of human oligodendrogliomas with the help of the NeuroShell Easy Classifier neural network.
Iglesias J; Esparza J; Scherf M
Anal Quant Cytol Histol; 2000 Oct; 22(5):383-92. PubMed ID: 11064814
[TBL] [Abstract][Full Text] [Related]
34. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
[TBL] [Abstract][Full Text] [Related]
35. [Malignancy grading of glial tumors. I. Astrocytomas].
Martin H; Schmidt D
Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
[TBL] [Abstract][Full Text] [Related]
36. Neural network-based segmentation and classification system for automated grading of histologic sections of bladder carcinoma.
Spyridonos P; Cavouras D; Ravazoula P; Nikiforidis G
Anal Quant Cytol Histol; 2002 Dec; 24(6):317-24. PubMed ID: 12508689
[TBL] [Abstract][Full Text] [Related]
37. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.
Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A
Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542
[TBL] [Abstract][Full Text] [Related]
38. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
39. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
40. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
